February 26, 2021
Business News

Revance Appoints Biotech and Pharmaceutical Executive, Olivia C. Ware, and Fintech and Payments Thought Leader and Entrepreneur, Carey O’Connor Kolaja, to its Board of Directors

NASHVILLE, Tenn.–()–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced the appointment of accomplished biotech and pharmaceutical executive, Olivia C. Ware, and fintech and payments thought leader and entrepreneur, Carey O’Connor Kolaja, to its Board of Directors. The appointments will be made effective on March 1, 2021 for Ms. Kolaja and March 6, 2021, for Ms. Ware.

“As we continue to grow and evolve our company strategy, it is critical that we expand the focus and expertise of our board. Olivia’s extensive background in drug portfolio and program management and Carey’s deep experience in fintech and payments…

Click here to view the original article.

Related Posts

You might also like ...

New TCF Banking Center Opens on West Seven Mile in Detroit
AM Best Removes From Under Review With Positive Implications and Upgrades Credit Ratings of National General Holdings Corp. and Its Subsidiaries
AON Splash Image
Hiro Capital leitet Venture-Capital-Investition von 15 Millionen US-Dollar in die Entwicklerstudios Snowprint Studios, Double Loop Games und Happy Volcano Games